# SG1906 for CLDN18.2-Positive Solid Tumors

> clinical trial · VERIFIED · 2026-07-10

Status: RECRUITING · Sponsor: Hangzhou Sumgen Biotech Co., Ltd. · Condition: Locally Advanced Unresectable or Metastatic Solid Tumors

- Company: Hangzhou Sumgen Biotech Co., Ltd.
- Sector: Locally Advanced Unresectable or Metastatic Solid Tumors
- Primary source: https://clinicaltrials.gov/study/NCT05857332

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.